TrialNeurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics2017

Donepezil Plus Solifenacin (CPC-201) Treatment for Alzheimer's Disease.

Thomas N Chase et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.